Nixon Peabody Trust’s Pfizer PFE Stock Holding History

Nixon Peabody Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$276K	Buy	11,474 +2,761	+32%	+$72.2K	0.02%	164
2026 Q1	$245K	Buy	8,713 +578	+7%	+$15.4K	0.02%	149
2025 Q4	$203K	Buy	+8,135	New	+$205K	0.02%	157
2022 Q3	–	Sell	-3,989	Closed	-$209K	–	72
2022 Q2	$209K	Sell	3,989 -2,280	-36%	-$116K	0.09%	69
2022 Q1	$325K	Sell	6,269 -1,129	-15%	-$58.6K	0.11%	64
2021 Q4	$437K	Buy	+7,398	New	+$367K	0.13%	65
2019 Q1	–	Sell	-5,166	Closed	-$214K	–	74
2018 Q4	$214K	Buy	5,166 +348	+7%	+$14.4K	0.17%	69
2018 Q3	$202K	Buy	+4,818	New	+$185K	0.14%	73
2016 Q3	–	Sell	-22,340	Closed	-$746K	–	81
2016 Q2	$746K	Sell	22,340 -105	-0.5%	-$3.35K	0.65%	53
2016 Q1	$631K	Sell	22,445 -550	-2%	-$15.7K	0.56%	58
2015 Q4	$704K	Buy	+22,995	New	+$723K	0.64%	57

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Nixon Peabody Trust's PFE Position: Q2 2026 in Review

Nixon Peabody Trust increased its Pfizer (PFE) stake by 32% in Q2 2026, buying an estimated $72.2K and bringing the position to 11,474 shares worth $276K. The position accounts for 0.02% of the portfolio, ranked #164.

Nixon Peabody Trust first reported a position in PFE in Q4 2015 and has held it in 11 quarters since. The position peaked at $746K in Q2 2016. 1,197 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Nixon Peabody Trust held 11,474 shares of Pfizer worth $276K as of Q2 2026.
Nixon Peabody Trust bought 2,761 Pfizer shares in Q2 2026, an estimated $72.2K.
Pfizer made up 0.02% of Nixon Peabody Trust's portfolio in Q2 2026, its #164 holding.
Nixon Peabody Trust first reported a position in Pfizer in Q4 2015 and has held it in 11 quarters since.
Nixon Peabody Trust's Pfizer position peaked at $746K in Q2 2016.
1,197 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.